ArticleJournal of inflammation research2025
A Machine Learning Model Integrating Preoperative Blood-Based Indices for Early and Noninvasive Detection of Endometrial Cancer.
Article in Journal of inflammation research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Endometrial cancer (EC) incidence is rising globally, yet early diagnosis remains challenging. Our objective is to develop a non-invasive, preoperative tool to predict EC risk using machine learning (ML) techniques. Methods: This retrospective analysis included clinical data from patients with endometrial lesions at the Third Affiliated Hospital of Sun Yat-sen University between January 2014 to August 2024. Six machine learning techniques including Random Forest (RF), Extreme Gradient Boosting (XGBoost), Support Vector Mac (SVM), Gradient Boosting Machine Model (GBDT), Logistic Regression (LR) and Multi-Layer Perceptron (MLP) were used to construct the prediction model of endometrial cancer. Receiver operating characteristic curve (ROC) was used to evaluate the model. S Hapley Additive ExPlanation (SHAP) analysis was applied to determine the predictive role of each feature in the model with the highest predictive performance. Results: A total of 857 patients were included in the study. Eight baseline characteristics (Age, BMI, Gravidity, Parity, Family history, Menopause status, Diabetes, Hypertension), one imaging feature (Endometrial thickness) and eight peripheral blood-based markers (WBC, NLR, MLR, PLR, SII, SIRI, CA-125, HE4) were selected for develop and validate the machine learning model, these features were obtained noninvasively. Data from 686 patients were randomly assigned to the training group, and data from 171 patients were used for internal validation. Among the six-machine learning model, GBDT had the highest prediction, the model achieved an AUC of 0.95 (95% CI: 0.93-0.97), accuracy of 90.0% and a Brier score of 0.06. The SHAP analysis showed that HE4, CA-125 and SIRI were the most influential contributors to the prediction. Conclusion: We developed and validated a GBDT prediction model, which showed the best performance in predicting endometrial cancer. This model can be applied in clinical practice to effectively predict the risk of EC for patients.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.